A Phase 2 clinical trial investigating the anti-virus effects, kinetics and safety of GS-5806 in adults with RSV (Respiratory Syncytial Virus) infection

Update Il y a 4 ans
Reference: EUCTR2014-002137-58

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to evaluate the effects of presatovir (GS-5806) on RSV viral load in RSV-positive adults hospitalized with acute respiratory infectious symptoms.


Inclusion criteria

  • Respiratory Syncytial Virus (RSV) Infection